Document is current
Any future updates will be listed below
-
Authors
Genoud, Sian
Chaichim, Chanchanok
Porto, Rossana Rosa
Tomanic, Tamara
Stefen, Holly
Paric, Esmeralda
Sarkar, Soumalya
Yoo, Dasol
Gao, Wendi
Hardeman, Edna C.
Gunning, Peter W.
Karl, Tim
Power, John
Fath, Thomas
-
Funding
Funding for this research was provided by:
Ainsworth Medical Research Innovation Fund
Dementia Australia Research Foundation
International Macquarie Research Excellence Scholarship
National Health and Medical Research Council (APP1083209, APP1083209, APP1083209)
Australian Research Council (DP180101473, DP180101473, DP180101473)
FightMND
NSW Health
Macquarie University
- License Information
-
More Information
Article History
Received: 20 January 2025
Accepted: 21 July 2025
First Online: 2 August 2025
Declarations
:
: Approval was obtained from the animal ethics committee of Macquarie University. The procedures used in this study adhere to the tenets of the Declaration of Helsinki.
: P.W.G. and E.C.H. are directors and shareholders of TroBio Therapeutics Pty Ltd., a company that is commercializing anti-tropomyosin drugs for the treatment of cancer. Their laboratories receive funding from TroBio to evaluate anti-tropomyosin drug candidates.
